BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeh CM, Lin CW, Yang JS, Yang WE, Su SC, Yang SF. Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation. Oncotarget 2016;7:21952-67. [PMID: 26980735 DOI: 10.18632/oncotarget.8009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen YY, Hsieh MJ, Hsieh YS, Chang YC, Chen PN, Yang SF, Ho HY, Chou YE, Lin CW. Antimetastatic effects of Rheum palmatum L. extract on oral cancer cells. Environ Toxicol 2017;32:2287-94. [PMID: 28678381 DOI: 10.1002/tox.22444] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
2 Chang PY, Hsieh MJ, Hsieh YS, Chen PN, Yang JS, Lo FC, Yang SF, Lu KH. Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways. Environ Toxicol 2017;32:2032-40. [PMID: 27860196 DOI: 10.1002/tox.22380] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
3 Su SC, Yeh CM, Lin CW, Hsieh YH, Chuang CY, Tang CH, Lee YC, Yang SF. A novel melatonin-regulated lncRNA suppresses TPA-induced oral cancer cell motility through replenishing PRUNE2 expression. J Pineal Res 2021;:e12760. [PMID: 34339541 DOI: 10.1111/jpi.12760] [Reference Citation Analysis]
4 Yang CY, Lin CK, Tsao CH, Hsieh CC, Lin GJ, Ma KH, Shieh YS, Sytwu HK, Chen YW. Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models. Oncotarget 2017;8:33756-69. [PMID: 28422711 DOI: 10.18632/oncotarget.16808] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
5 Chung HH, Chen MK, Chang YC, Yang SF, Lin CC, Lin CW. Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells. Environ Toxicol 2017;32:1765-74. [PMID: 28181379 DOI: 10.1002/tox.22399] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
6 Yeh CM, Su SC, Lin CW, Yang WE, Chien MH, Reiter RJ, Yang SF. Melatonin as a potential inhibitory agent in head and neck cancer. Oncotarget 2017;8:90545-56. [PMID: 29163852 DOI: 10.18632/oncotarget.20079] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
7 Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, Li HB. Melatonin for the prevention and treatment of cancer.Oncotarget. 2017;8:39896-39921. [PMID: 28415828 DOI: 10.18632/oncotarget.16379] [Cited by in Crossref: 137] [Cited by in F6Publishing: 125] [Article Influence: 34.3] [Reference Citation Analysis]
8 Chen JM, Chen PY, Lin CC, Hsieh MC, Lin JT. Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2. Molecules 2020;25:E2248. [PMID: 32397656 DOI: 10.3390/molecules25092248] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lin YW, Wang SS, Wen YC, Tung MC, Lee LM, Yang SF, Chien MH. Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma. Int J Med Sci 2017;14:1130-5. [PMID: 29104467 DOI: 10.7150/ijms.20629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Gurunathan S, Kang MH, Kim JH. Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers. Cancers (Basel) 2020;12:E1567. [PMID: 32545820 DOI: 10.3390/cancers12061567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Hsin CH, Chou YE, Yang SF, Su SC, Chuang YT, Lin SH, Lin CW. MMP-11 promoted the oral cancer migration and Fak/Src activation. Oncotarget 2017;8:32783-93. [PMID: 28427180 DOI: 10.18632/oncotarget.15824] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
12 Bojková B, Kubatka P, Qaradakhi T, Zulli A, Kajo K. Melatonin May Increase Anticancer Potential of Pleiotropic Drugs. Int J Mol Sci 2018;19:E3910. [PMID: 30563247 DOI: 10.3390/ijms19123910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chung TT, Chuang CY, Teng YH, Hsieh MJ, Lai JC, Chuang YT, Chen MK, Yang SF. Tricetin suppresses human oral cancer cell migration by reducing matrix metalloproteinase-9 expression through the mitogen-activated protein kinase signaling pathway. Environ Toxicol 2017;32:2392-9. [PMID: 28731287 DOI: 10.1002/tox.22452] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
14 Liu R, Wang HL, Deng MJ, Wen XJ, Mo YY, Chen FM, Zou CL, Duan WF, Li L, Nie X. Melatonin Inhibits Reactive Oxygen Species-Driven Proliferation, Epithelial-Mesenchymal Transition, and Vasculogenic Mimicry in Oral Cancer. Oxid Med Cell Longev 2018;2018:3510970. [PMID: 29725496 DOI: 10.1155/2018/3510970] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
15 González A, Alonso-González C, González-González A, Menéndez-Menéndez J, Cos S, Martínez-Campa C. Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments. Cancers (Basel) 2021;13:3263. [PMID: 34209857 DOI: 10.3390/cancers13133263] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Qu H, Xue Y, Lian W, Wang C, He J, Fu Q, Zhong L, Lin N, Lai L, Ye Z, Wang Q. Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling. Life Sci 2018;207:253-64. [PMID: 29689273 DOI: 10.1016/j.lfs.2018.04.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
17 Zhang Q, Zhang Y, Hu X, Qin Y, Zhong W, Meng J, Xiao T, Zhang C, Li M, Chen S, Liu H, Liu Y, Sun T, Yang C. Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma. Lab Invest 2017;97:903-12. [DOI: 10.1038/labinvest.2017.51] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
18 Cheng HL, Liu YF, Su CW, Su SC, Chen MK, Yang SF, Lin CW. Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk. Oncotarget 2016;7:69384-96. [PMID: 27655721 DOI: 10.18632/oncotarget.12082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
19 Hsieh MJ, Lin CW, Su SC, Reiter RJ, Chen AW, Chen MK, Yang SF. Effects of miR-34b/miR-892a Upregulation and Inhibition of ABCB1/ABCB4 on Melatonin-Induced Apoptosis in VCR-Resistant Oral Cancer Cells. Mol Ther Nucleic Acids 2020;19:877-89. [PMID: 31982774 DOI: 10.1016/j.omtn.2019.12.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
20 Reiter RJ, Rosales-Corral SA, Tan DX, Acuna-Castroviejo D, Qin L, Yang SF, Xu K. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis. Int J Mol Sci 2017;18:E843. [PMID: 28420185 DOI: 10.3390/ijms18040843] [Cited by in Crossref: 187] [Cited by in F6Publishing: 178] [Article Influence: 37.4] [Reference Citation Analysis]
21 Liu S, Liang B, Jia H, Jiao Y, Pang Z, Huang Y. Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells. FEBS Open Bio 2017;7:798-810. [PMID: 28593135 DOI: 10.1002/2211-5463.12223] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
22 Liu H, Li J, Yang Y, Liu L, Yu L, Tu M, Yuan R, Yue W, Luo Q, Ruan Y, Dai X. Alterations of 63 hub genes during lingual carcinogenesis in C57BL/6J mice. Sci Rep 2018;8:12626. [PMID: 30135512 DOI: 10.1038/s41598-018-31103-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Bondy SC, Campbell A. Mechanisms Underlying Tumor Suppressive Properties of Melatonin. Int J Mol Sci 2018;19:E2205. [PMID: 30060531 DOI: 10.3390/ijms19082205] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
24 Chu YH, Su CW, Hsieh YS, Chen PN, Lin CW, Yang SF. Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Cells 2020;9:E704. [PMID: 32183030 DOI: 10.3390/cells9030704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
25 Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Stoian AP, Jinga V, Nitipir C, Bucur A, Pituru TS, Arsene AL, Dragoi CM, Hainarosie R, Nicolae AC, Gherghe M, Gheorghe DC, Spandidos DA, Tsatsakis A, Papasavva M, Drakoulis N. Clinical significance of serum melatonin in predicting the severity of oral squamous cell carcinoma. Oncol Lett 2020;19:1537-43. [PMID: 31966079 DOI: 10.3892/ol.2019.11215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
26 Jiang YW, Cheng HY, Kuo CL, Way TD, Lien JC, Chueh FS, Lin YL, Chung JG. Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro. Environ Toxicol 2019;34:364-74. [PMID: 30549224 DOI: 10.1002/tox.22691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
27 Pourhanifeh MH, Mehrzadi S, Kamali M, Hosseinzadeh A. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways. Eur J Pharmacol 2020;886:173471. [PMID: 32877658 DOI: 10.1016/j.ejphar.2020.173471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
28 Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules 2021;26:2506. [PMID: 33923028 DOI: 10.3390/molecules26092506] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
29 Liu G, Zhan W, Guo W, Hu F, Qin J, Li R, Liao X. MELK Accelerates the Progression of Colorectal Cancer via Activating the FAK/Src Pathway. Biochem Genet 2020;58:771-82. [DOI: 10.1007/s10528-020-09974-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Lee C, Yang S, Wang P, Su C, Hsu H, Tsai H, Hsiao Y. Antimetastatic effects of Terminalia catappa leaf extracts on cervical cancer through the inhibition of matrix metalloprotein‐9 and MAPK pathway. Environmental Toxicology 2018;34:60-6. [DOI: 10.1002/tox.22657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Dai L, Chen L, Wang W, Lin P. Resveratrol inhibits ACHN cells via regulation of histone acetylation. Pharm Biol 2020;58:231-8. [PMID: 32202448 DOI: 10.1080/13880209.2020.1738503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Yang JS, Lin CW, Hsieh YH, Chien MH, Chuang CY, Yang SF. Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells. Oncotarget 2017;8:83088-99. [PMID: 29137326 DOI: 10.18632/oncotarget.20236] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
33 Léger C, Dupré N, Laquerrière A, Lecointre M, Dumanoir M, Janin F, Hauchecorne M, Fabre M, Jégou S, Frébourg T, Cleren C, Leroux P, Marcorelles P, Brasse-Lagnel C, Marret S, Marguet F, Gonzalez BJ. In utero alcohol exposure exacerbates endothelial protease activity from pial microvessels and impairs GABA interneuron positioning. Neurobiol Dis 2020;145:105074. [PMID: 32890773 DOI: 10.1016/j.nbd.2020.105074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Huang CF, Teng YH, Lu FJ, Hsu WH, Lin CL, Hung CC, Tung JN, Hsieh YH, Liu CJ. β-mangostin suppresses human hepatocellular carcinoma cell invasion through inhibition of MMP-2 and MMP-9 expression and activating the ERK and JNK pathways. Environ Toxicol 2017;32:2360-70. [PMID: 28722351 DOI: 10.1002/tox.22449] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
35 Salarić I, Karmelić I, Lovrić J, Baždarić K, Rožman M, Čvrljević I, Zajc I, Brajdić D, Macan D. Salivary melatonin in oral squamous cell carcinoma patients. Sci Rep 2021;11:13201. [PMID: 34168230 DOI: 10.1038/s41598-021-92649-3] [Reference Citation Analysis]
36 Yang SL, Kuo FH, Chen PN, Hsieh YH, Yu NY, Yang WE, Hsieh MJ, Yang SF. Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression. Oncotarget 2017;8:105860-72. [PMID: 29285298 DOI: 10.18632/oncotarget.22407] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
37 Yang H, Jin X, Dan H, Chen Q. Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders. Oral Dis 2020;26:719-32. [DOI: 10.1111/odi.13115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Kayahara GM, Valente VB, Pereira RB, Lopes FYK, Crivelini MM, Miyahara GI, Biasoli ÉR, Oliveira SHP, Bernabé DG. Pineal gland protects against chemically induced oral carcinogenesis and inhibits tumor progression in rats. Oncotarget 2020;11:1816-31. [PMID: 32499868 DOI: 10.18632/oncotarget.27551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Li YT, Wang YC, Lee HL, Lu MC, Yang SF. Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia. Int J Med Sci 2016;13:638-45. [PMID: 27499696 DOI: 10.7150/ijms.16187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
40 Lee HL, Chiou HL, Wang SS, Hung SC, Chou MC, Yang SF, Hsieh MJ, Chou YE. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma. Urol Oncol 2018;36:160.e15-21. [PMID: 29277583 DOI: 10.1016/j.urolonc.2017.11.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Capote-Moreno A, Ramos E, Egea J, López-Muñoz F, Gil-Martín E, Romero A. Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics. Cancers (Basel) 2019;11:E1712. [PMID: 31684096 DOI: 10.3390/cancers11111712] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
42 Chao YH, Wu KH, Yeh CM, Su SC, Reiter RJ, Yang SF. The potential utility of melatonin in the treatment of childhood cancer. J Cell Physiol 2019;234:19158-66. [PMID: 30945299 DOI: 10.1002/jcp.28566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Bjørklund G, Rajib SA, Saffoon N, Pen JJ, Chirumbolo S. Insights on Melatonin as an Active Pharmacological Molecule in Cancer Prevention: What's New? Curr Med Chem 2019;26:6304-20. [PMID: 29714136 DOI: 10.2174/0929867325666180501094850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Pantea-Stoian A, Nitipir C, Gheorghe DC. Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma. Oncol Lett 2020;19:3011-20. [PMID: 32218858 DOI: 10.3892/ol.2020.11392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Bhattacharya S, Patel KK, Dehari D, Agrawal AK, Singh S. Melatonin and its ubiquitous anticancer effects. Mol Cell Biochem 2019;462:133-55. [DOI: 10.1007/s11010-019-03617-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
46 Ho H, Lin C, Chien M, Reiter RJ, Su S, Hsieh Y, Yang S. Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma. J Pineal Res 2016;61:479-92. [DOI: 10.1111/jpi.12365] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
47 Mirza-Aghazadeh-Attari M, Reiter RJ, Rikhtegar R, Jalili J, Hajalioghli P, Mihanfar A, Majidinia M, Yousefi B. Melatonin: An atypical hormone with major functions in the regulation of angiogenesis. IUBMB Life 2020;72:1560-84. [PMID: 32329956 DOI: 10.1002/iub.2287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
48 Hsin C, Huang C, Chen P, Hsieh Y, Yang S, Ho Y, Lin C. Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway. Am J Chin Med 2017;45:1557-72. [DOI: 10.1142/s0192415x17500847] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
49 Ahmed E, Shaker OG, Yussif N, Ghalwash DM. Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial. Int J Dent 2021;2021:8840167. [PMID: 33628250 DOI: 10.1155/2021/8840167] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Su S, Hsieh M, Yang W, Chung W, Reiter RJ, Yang S. Cancer metastasis: Mechanisms of inhibition by melatonin. J Pineal Res 2017;62:e12370. [DOI: 10.1111/jpi.12370] [Cited by in Crossref: 148] [Cited by in F6Publishing: 166] [Article Influence: 24.7] [Reference Citation Analysis]
51 Park HK, Hwang DS, Kim GC, Jang MA, Kim UK. Effects of melatonin receptor expression on prognosis and survival in oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg 2021:S0901-5027(21)00290-3. [PMID: 34483028 DOI: 10.1016/j.ijom.2021.08.015] [Reference Citation Analysis]
52 Najeeb S, Khurshid Z, Zohaib S, Zafar MS. Therapeutic potential of melatonin in oral medicine and periodontology. Kaohsiung J Med Sci 2016;32:391-6. [PMID: 27523451 DOI: 10.1016/j.kjms.2016.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]